Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-23
1998-02-24
Rotman, Alan L.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
514183, 514210, 514318, 514320, 514321, 514322, 514324, 546193, 546195, 546196, 546197, 546198, 546199, 546201, 546202, 546209, 546270, 546271, 546273, 546274, A61K 31445, C07D40106, C07D40112, C07D40506
Patent
active
057212538
ABSTRACT:
Fibrinogen receptor antagonists of the formula: ##STR1## are disclosed for use in inhibiting the binding of fibrinogen to blood platelets and for inhibiting the aggregation of blood platelets.
REFERENCES:
Hartman GD et al. J. Med. Chem. 35, 4640-4642, 1992.
Ford-Hutchinson AW. et al. Can. J. Physiol. Pharmacol. 67, 989-993, 1989.
Askew Ben
Egbertson Melissa S.
Halczenko Wasyl
Hartman George D.
Huang Evelyn
Merck & Co. , Inc.
Parr Richard S.
Rotman Alan L.
Winokur Melvin
LandOfFree
Fibrinogen receptor antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Fibrinogen receptor antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Fibrinogen receptor antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1875489